Oncology & Cancer

Novel bioassay predicts cancer patients' response to immunotherapy

A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...

Oncology & Cancer

Blood-based 'liquid biopsy' might spot early-stage cancers

An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy—including some that are particularly tricky to detect, a preliminary study suggests.

Diseases, Conditions, Syndromes

Enhancing at-home COVID tests with glow-in-the dark materials

Researchers at the University of Houston are using glow-in-the-dark materials to enhance and improve rapid COVID-19 home tests. If you've taken an at-home COVID-19 or pregnancy test, then you've taken what is scientifically ...

page 1 from 22